Susan E. Dorman

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

Payam Nahid, Susan E. Dorman, Narges Alipanah et al. · Clinical Infectious Diseases · 2016 · 1.4K citations · Full text

Tuberculosis Treatment, Tuberculosis Prevention, Pediatric Lung Disease +21

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

Susan E. Dorman, Samuel G. Schumacher, David Alland et al. · The Lancet Infectious Diseases · 2017 · 666 citations · Full text

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · New England Journal of Medicine · 2021 · 521 citations · Full text

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

Emmanuelle Jouanguy, Salma Lamhamedi‐Cherradi, David A. Lammas et al. · Nature Genetics · 1999 · 486 citations

Medical Microbiology, Microbial Disease, Pathogenesis +8

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

Susan E. Dorman, Steven M. Holland · Journal of Clinical Investigation · 1998 · 423 citations · Full text

Disseminated Mycobacterium Fortuitum, Microbial Pathogens, Immunodeficiencies +20